Federal health officials announced an immediate reduction in the CDC’s routine pediatric vaccine recommendations to 11 diseases, a change implemented under HHS direction and outside the Advisory Committee for Immunization Practices’ normal deliberative process. Acting CDC leadership said the schedule was revised to align with peer nations; critics noted the move bypassed usual independent scientific review. The policy shift affects recommendations for vaccines such as hepatitis A/B, RSV and flu, which will be moved from universal to risk‑based or shared decision‑making guidance.